November kicked off with a 12 IPO week and shoe brand Allbirds (BIRD) was at the front of the flock, posting a first-day pop of 93%. 23 SPACs also went public. New issuers continued to join the pipeline, with five IPOs and 13 SPACs submitting...read more
MDxHealth, a Belgian provider of genomic testing products for prostate cancer, raised $45 million by offering 3.8 million ADSs at $12, above the as-converted last close of its shares on the Euronext Brussels ($11.70). MDxHealth is a...read more
Updated Monday, 11/1. The IPO market has seen double digit offerings for the past two weeks, and is scheduled to continue its streak, with 13 IPOs expected to raise $2.7 billion. Drug discovery company Evotec (EVO) plans to raise...read more
MDxHealth, a Belgian provider of genomic testing products for prostate cancer, announced terms for its IPO on Thursday. The Herstal, Belgium-based company plans to raise $50 million by offering 3.8 million shares at $13.46, equivalent to the company's...read more
US IPO Weekly Recap: Allbirds spreads its wings and soars 93% in a 12 IPO week
November kicked off with a 12 IPO week and shoe brand Allbirds (BIRD) was at the front of the flock, posting a first-day pop of 93%. 23 SPACs also went public. New issuers continued to join the pipeline, with five IPOs and 13 SPACs submitting...read more
Belgium-listed diagnostics company MDxHealth prices US IPO at $12
MDxHealth, a Belgian provider of genomic testing products for prostate cancer, raised $45 million by offering 3.8 million ADSs at $12, above the as-converted last close of its shares on the Euronext Brussels ($11.70). MDxHealth is a...read more
US IPO Week Ahead: Steady IPO deal flow set to continue with 13 IPOs slated for next week
Updated Monday, 11/1. The IPO market has seen double digit offerings for the past two weeks, and is scheduled to continue its streak, with 13 IPOs expected to raise $2.7 billion. Drug discovery company Evotec (EVO) plans to raise...read more
Belgium-listed diagnostics company MDxHealth sets terms for $50 million IPO
MDxHealth, a Belgian provider of genomic testing products for prostate cancer, announced terms for its IPO on Thursday. The Herstal, Belgium-based company plans to raise $50 million by offering 3.8 million shares at $13.46, equivalent to the company's...read more